-
Je něco špatně v tomto záznamu ?
HbA1c but not diabetes duration predicts increased arterial stiffness in adolescents with poorly controlled type 1 diabetes
B. Obermannova, L. Petruzelkova, T. Sulakova, Z. Sumnik,
Jazyk angličtina Země Dánsko
Typ dokumentu časopisecké články
Grantová podpora
NT14335
MZ0
CEP - Centrální evidence projektů
PubMed
27075550
DOI
10.1111/pedi.12385
Knihovny.cz E-zdroje
- MeSH
- analýza pulzové vlny MeSH
- biologické markery krev MeSH
- diabetes mellitus 1. typu krev komplikace patofyziologie terapie MeSH
- diabetická kardiomyopatie epidemiologie prevence a kontrola MeSH
- diabetické angiopatie epidemiologie prevence a kontrola MeSH
- glykovaný hemoglobin analýza MeSH
- hyperglykemie prevence a kontrola MeSH
- kardiovaskulární nemoci komplikace epidemiologie prevence a kontrola MeSH
- kohortové studie MeSH
- kombinovaná terapie MeSH
- konziliární vyšetření a konzultace MeSH
- lidé MeSH
- mladiství MeSH
- nemocnice univerzitní MeSH
- prevalence MeSH
- progrese nemoci MeSH
- průřezové studie MeSH
- rizikové faktory MeSH
- tuhost cévní stěny * MeSH
- Check Tag
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika epidemiologie MeSH
BACKGROUND: The prevalence of macrovascular complications is probably underestimated in children with type 1 diabetes (T1D). Arterial stiffness (AS) is a subclinical marker of cardiovascular (CV) risk. The most validated, non-invasive method for AS measurement is pulse wave velocity (PWV). Only a few PWV studies have been performed in children with T1D. OBJECTIVE: To explore the risk factors associated with AS in adolescents with suboptimally controlled T1D. PATIENTS AND METHODS: Seventy-seven adolescents with T1D were included (39 girls, 38 boys) in this study. The adolescents had a median age of 16 yr (IQR 14-17), median duration of T1D was 9 yr (IQR 6-16), and HbA1c 71 mmol/mol (median, IQR 62-81). PWV was measured as the carotid-femoral pulse transmission time and converted into standard deviation scores (SDS) (adjusted for gender and age) using normative values for children. The risk factors assessed were HbA1c, T1D duration, treatment modality, serum lipids, and blood pressure (BP) measured via ambulatory blood pressure monitoring (ABPM). RESULTS: The PWV did not differ from the reference data (median PWV was 5.1 m/s, i.e., -0.01 SDS). A significant positive association was observed between PWV-SDS and HbA1c (p = 0.001), total cholesterol (p = 0.003), LDL-cholesterol (p = 0.003), but not T1D duration (p = 0.78) according to the univariate analyses. In the multivariate model, the only significant variable that remained positively associated with PWV-SDS was HbA1c (p = 0.03). CONCLUSIONS: Most adolescents with suboptimally controlled T1D have normal mean PWV compared to a healthy reference population. Chronic hyperglycemia, not T1D duration, is the main predictor of AS in adolescents.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18011263
- 003
- CZ-PrNML
- 005
- 20190918144251.0
- 007
- ta
- 008
- 180404s2017 dk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/pedi.12385 $2 doi
- 035 __
- $a (PubMed)27075550
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a dk
- 100 1_
- $a Obermannová, Barbora $u Department of Pediatrics, University Hospital Motol and 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. $7 xx0173310
- 245 10
- $a HbA1c but not diabetes duration predicts increased arterial stiffness in adolescents with poorly controlled type 1 diabetes / $c B. Obermannova, L. Petruzelkova, T. Sulakova, Z. Sumnik,
- 520 9_
- $a BACKGROUND: The prevalence of macrovascular complications is probably underestimated in children with type 1 diabetes (T1D). Arterial stiffness (AS) is a subclinical marker of cardiovascular (CV) risk. The most validated, non-invasive method for AS measurement is pulse wave velocity (PWV). Only a few PWV studies have been performed in children with T1D. OBJECTIVE: To explore the risk factors associated with AS in adolescents with suboptimally controlled T1D. PATIENTS AND METHODS: Seventy-seven adolescents with T1D were included (39 girls, 38 boys) in this study. The adolescents had a median age of 16 yr (IQR 14-17), median duration of T1D was 9 yr (IQR 6-16), and HbA1c 71 mmol/mol (median, IQR 62-81). PWV was measured as the carotid-femoral pulse transmission time and converted into standard deviation scores (SDS) (adjusted for gender and age) using normative values for children. The risk factors assessed were HbA1c, T1D duration, treatment modality, serum lipids, and blood pressure (BP) measured via ambulatory blood pressure monitoring (ABPM). RESULTS: The PWV did not differ from the reference data (median PWV was 5.1 m/s, i.e., -0.01 SDS). A significant positive association was observed between PWV-SDS and HbA1c (p = 0.001), total cholesterol (p = 0.003), LDL-cholesterol (p = 0.003), but not T1D duration (p = 0.78) according to the univariate analyses. In the multivariate model, the only significant variable that remained positively associated with PWV-SDS was HbA1c (p = 0.03). CONCLUSIONS: Most adolescents with suboptimally controlled T1D have normal mean PWV compared to a healthy reference population. Chronic hyperglycemia, not T1D duration, is the main predictor of AS in adolescents.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a kardiovaskulární nemoci $x komplikace $x epidemiologie $x prevence a kontrola $7 D002318
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a kombinovaná terapie $7 D003131
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a Česká republika $x epidemiologie $7 D018153
- 650 _2
- $a diabetes mellitus 1. typu $x krev $x komplikace $x patofyziologie $x terapie $7 D003922
- 650 _2
- $a diabetické angiopatie $x epidemiologie $x prevence a kontrola $7 D003925
- 650 _2
- $a diabetická kardiomyopatie $x epidemiologie $x prevence a kontrola $7 D058065
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a glykovaný hemoglobin $x analýza $7 D006442
- 650 _2
- $a nemocnice univerzitní $7 D006785
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hyperglykemie $x prevence a kontrola $7 D006943
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a analýza pulzové vlny $7 D063177
- 650 _2
- $a konziliární vyšetření a konzultace $7 D012017
- 650 _2
- $a rizikové faktory $7 D012307
- 650 12
- $a tuhost cévní stěny $7 D059289
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Petruželková, Lenka $u Department of Pediatrics, University Hospital Motol and 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. $7 xx0169238
- 700 1_
- $a Šuláková, Terezie $u Department of Pediatrics, University Hospital and Medical Faculty, University of Ostrava, Ostrava, Czech Republic. $7 xx0106735
- 700 1_
- $a Šumník, Zdeněk, $u Department of Pediatrics, University Hospital Motol and 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. $d 1970- $7 xx0036973
- 773 0_
- $w MED00181048 $t Pediatric diabetes $x 1399-5448 $g Roč. 18, č. 4 (2017), s. 304-310
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27075550 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20190918144640 $b ABA008
- 999 __
- $a ok $b bmc $g 1288748 $s 1008075
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 18 $c 4 $d 304-310 $e 20160414 $i 1399-5448 $m Pediatric diabetes $n Pediatr Diabetes $x MED00181048
- GRA __
- $a NT14335 $p MZ0
- LZP __
- $a Pubmed-20180404